Day: June 20, 2025

VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) (“Rakovina” or the “Company”) is pleased to announce that the effective date for the previously announced share consolidation (the “Consolidation”) will be June 24, 2025. As outlined in the Company’s news release dated May 15, 2025, the Consolidation will be conducted on the basis of one (1) post-consolidation common share (“Post-Consolidation Share”) for every ten (10) pre-consolidation common shares (“Pre-Consolidation Share”). The Post-Consolidation Shares are scheduled to begin trading on the TSX Venture Exchange (the “TSX-V”) at the market open on June 24, 2025 under the existing symbol “RKV”. Following the Consolidation, the new CUSIP number for the common shares will be 75103L309 and the new ISIN number will be...

Strategic Expansion Targets Long-Term Revenue Growth and Innovation in Commodity Finance SINGAPORE, June 20, 2025 (GLOBE NEWSWIRE) — Davis Commodities Limited (Nasdaq: DTCK), a Singapore-based leader in agricultural commodities trading, has unveiled a strategic plan to integrate blockchain technology and digital assets into its business operations. The company has announced the upcoming launch of a digital asset treasury management strategy alongside a real-world asset (RWA) tokenization platform, highlighting its intent to revolutionize commodity finance and unlock significant growth opportunities in the global digital economy. The company has outlined a $30 million fundraising plan and, upon successful completion, intends to deploy a dual-pronged strategy designed to drive innovation and revenue growth. The initiative aligns...

REMARKABLY PRESERVED 1962 SHELBY 260 COBRA, ONE OF THE ORIGINAL PROTOTYPE EXAMPLES, OFFERED FROM 36 YEARS OF CHERISHED LONGTERM OWNERSHIP | COBRA JOINED BY MODERN AMERICAN AUTOMOTIVE LEGENDS: HENNESSEY VENOM GT AND THE AMERICAN PERFORMANCE COLLECTION OF DODGE AND CHEVROLET ICONSThe 1962 Shelby 260 Cobra, CSX 2003, to be offered at Broad Arrow’s 2025 Monterey Jet Center Auction(Credit – Andrew Benjack / Courtesy of Broad Arrow Auctions)A pair of limited-edition Dodge Vipers offered from The American Performance Collection at Broad Arrow’s 2025 Monterey Jet Center Auction(Credit – Nick Zabrecky / Courtesy of Broad Arrow Auctions)Grosse Pointe, Michigan, June 20, 2025 (GLOBE NEWSWIRE) — Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, is honored to announce the presentation of one of the earliest Cobras ever...

AUGA group, AB entity under restructuring (code 126264360, registered office at Konstitucijos pr. 21C, Vilnius, hereinafter referred to as the “Company”), by the initiative and decision of the Board, is convening an Extraordinary General meeting of shareholders on July 14, 2025, at 10:00 a.m., where the Company’s shareholders will vote on the approval of the Company’s draft restructuring plan, hereinafter referred to as the “Meeting”. The Meeting will be held at the conference room at the business center QUADRUM NORTH, address Konstitucijos ave. 21C, Vilnius. The registration of the shareholders begins at 10.00 a.m. Only those persons who will be shareholders of the Company at the close of the record date of the Meeting may participate and vote at the Meeting. The record date of the Meeting shall be 7th July 2025. Agenda of the Meeting: 1....

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the expiration and preliminary expiration date results of its Exchange Offers (as defined below) and the expiration of its Cash Offers (as defined below). Exchange Offers The first transaction consists of 10 separate private offers to exchange (the “Exchange Offers”) any and all of the outstanding series of notes listed in the table below (as used in the context of the Exchange Offers and the Cash Offers (as defined below), collectively the “Old Notes”) in exchange for newly issued 5.401% Notes due 2037 of Verizon (the “New Notes”), on the terms and subject to the conditions set forth in the Offering Memorandum dated June 12, 2025 (the “Offering Memorandum”), the eligibility letter (the “Eligibility Letter”) and...

The Board of Directors of SBA Group company Utenos Trikotažas has unanimously re-elected Vytautas Vaškys as Chairman. This decision follows the election of a new Board on April 30, 2025, with no changes to its composition. Mr. Vaškys has chaired the Board since November 2024, succeeding Dovilė Tamoševičienė, who had held the position for three years. He has been involved with Utenos Trikotažas for several years, having previously served on the Board and temporarily assumed the role of CEO in 2022. Mr. Vaškys currently leads the SBA Group’s Business Risk Division and is actively engaged in the governance of other SBA Group companies. According to Mr. Vaškys, the company’s main strategic objective remains unchanged: to ensure the smooth implementation of the restructuring plan and restore sustainable profitability. The four-year restructuring...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. This press release constitutes a “designated news release” for the purposes of the Trust’s amended and restated prospectus supplement dated December 6, 2024 to its base shelf prospectus dated January 3, 2024. TORONTO, June 20, 2025 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott”) on behalf of the Sprott Physical Uranium Trust (TSX: U.UN) (TSX: U.U) (“SPUT” or the “Trust”), is pleased to announce the closing of its previously announced upsized bought deal public offering (the “Offering”), pursuant to which 11,600,000 units of the Trust (the “Units”) were issued at a price of US$17.25 per Unit for total gross proceeds of approximately US$200...

Four-year data show preservation of cardiac function, including LVEF Skeletal muscle disease progression continues to slow with extended treatment (PUL v2.0) Deramiocel’s long-term safety profile remains favorable Results presented at PPMD’s 2025 Annual ConferenceSAN DIEGO, June 20, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive four-year safety and efficacy results from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the Company’s lead cell therapy candidate for Duchenne Muscular Dystrophy (DMD). The data will be featured in the session titled “Therapies that Slow Progression” at the Parent Project Muscular Dystrophy (PPMD) 2025 Annual Conference, taking place June...